Current and historical daily PE Ratio for Sakar Healthcare Ltd (
NSE:SAKAR
) from 2016 to Apr 16 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Sakar Healthcare stock (NSE:SAKAR) PE ratio as of Apr 16 2024 is 60.49.
More Details
Sakar Healthcare Ltd (NSE:SAKAR) PE Ratio (TTM) Chart
Sakar Healthcare Ltd (NSE:SAKAR) PE Ratio (TTM) Historical Data
View and export this data going back to 2016. Start your Free Trial
Total 1078
- 1
- 2
- 3
- 4
- 5
- 6
- 12
| Sakar Healthcare PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-04-16 | 60.5 | 2023-12-26 | 54.7 |
| 2024-03-05 | 60.5 | 2023-12-22 | 49.8 |
| 2024-03-04 | 59.3 | 2023-12-21 | 49.7 |
| 2024-02-29 | 59.2 | 2023-12-20 | 48.5 |
| 2024-02-27 | 61.1 | 2023-12-19 | 50.2 |
| 2024-02-26 | 61.5 | 2023-12-18 | 49.8 |
| 2024-02-23 | 62.6 | 2023-12-15 | 50.0 |
| 2024-02-22 | 62.0 | 2023-12-14 | 50.5 |
| 2024-02-21 | 62.3 | 2023-12-13 | 50.6 |
| 2024-02-20 | 63.2 | 2023-12-12 | 50.8 |
| 2024-02-19 | 64.5 | 2023-12-11 | 50.7 |
| 2024-02-16 | 65.5 | 2023-12-08 | 50.8 |
| 2024-02-15 | 65.7 | 2023-12-07 | 50.9 |
| 2024-02-14 | 62.8 | 2023-12-06 | 51.4 |
| 2024-02-13 | 62.2 | 2023-12-05 | 51.1 |
| 2024-02-12 | 61.3 | 2023-12-04 | 51.7 |
| 2024-02-09 | 68.7 | 2023-12-01 | 52.4 |
| 2024-02-08 | 67.6 | 2023-11-30 | 52.8 |
| 2024-02-07 | 67.2 | 2023-11-29 | 53.5 |
| 2024-02-06 | 67.4 | 2023-11-28 | 52.6 |
| 2024-02-05 | 67.4 | 2023-11-24 | 53.1 |
| 2024-02-02 | 67.3 | 2023-11-23 | 53.8 |
| 2024-02-01 | 67.7 | 2023-11-22 | 54.5 |
| 2024-01-31 | 68.5 | 2023-11-21 | 55.0 |
| 2024-01-30 | 69.0 | 2023-11-20 | 51.4 |
| 2024-01-25 | 70.5 | 2023-11-17 | 51.9 |
| 2024-01-24 | 70.9 | 2023-11-16 | 52.3 |
| 2024-01-23 | 66.9 | 2023-11-15 | 52.3 |
| 2024-01-19 | 68.0 | 2023-11-13 | 51.9 |
| 2024-01-17 | 66.0 | 2023-11-10 | 52.5 |
| 2024-01-16 | 65.6 | 2023-11-09 | 51.0 |
| 2024-01-15 | 66.5 | 2023-11-08 | 49.5 |
| 2024-01-12 | 65.9 | 2023-11-07 | 49.9 |
| 2024-01-11 | 66.0 | 2023-11-06 | 50.2 |
| 2024-01-10 | 66.0 | 2023-11-03 | 46.7 |
| 2024-01-09 | 64.7 | 2023-11-02 | 46.1 |
| 2024-01-08 | 68.2 | 2023-11-01 | 45.4 |
| 2024-01-05 | 65.3 | 2023-10-31 | 45.2 |
| 2024-01-04 | 65.9 | 2023-10-30 | 45.1 |
| 2024-01-03 | 65.0 | 2023-10-20 | 48.4 |
| 2024-01-02 | 65.4 | 2023-10-19 | 48.2 |
| 2024-01-01 | 65.7 | 2023-10-18 | 48.6 |
| 2023-12-29 | 64.2 | 2023-10-17 | 49.4 |
| 2023-12-28 | 63.9 | 2023-10-16 | 49.3 |
| 2023-12-27 | 54.1 | 2023-10-12 | 48.7 |
Sakar Healthcare Ltd (NSE:SAKAR) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Sakar Healthcare Ltd
ISIN : INE732S01012
Compare
Compare
Traded in other countries / regions
SAKAR.India IPO Date
2016-10-14Description
Sakar Healthcare Ltd is engaged in manufacturing Pharmaceutical products providing Liquid Orals, Cephalosporin Tablet, Capsule, Dry Powder Syrup, Dry Powder Injections, Liquid Injectables (SVP) in Ampoules and Vials & Lyophilized Injections. The company offers its products to Sri Lanka, the Philippines, Vietnam, Cambodia, Sudan, Myanmar, Mauritius, Costa Rica, Panama, El Salvador, and Paraguay.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers